Treace Medical Concepts, Inc. Shareholders' Equity
Treace Medical Concepts, Inc. (TMCI) had Shareholders' Equity of $67.74 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-07
- 2026-06-30: Stockholders' Equity Attributable to Parent $67.74M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $77.19M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $87.33M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $89.19M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $67.74M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $77.19M 10-Q · filed 2026-08-07 |
| 2025-12-31 | $87.33M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $89.19M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $97.61M 10-Q · filed 2026-08-07 |
| 2025-03-31 | $105.34M 10-Q · filed 2026-08-07 |
| 2024-12-31 | $112.89M 10-Q · filed 2026-08-07 |
| 2024-09-30 | $104.91M 10-Q · filed 2025-11-06 |
| 2024-06-30 | $112.14M 10-Q · filed 2025-11-06 |
| 2024-03-31 | $126.39M 10-Q · filed 2025-11-06 |
| 2023-12-31 | $137.94M 10-K · filed 2026-02-27 |
| 2023-09-30 | $137.86M 10-Q · filed 2024-11-05 |
| 2023-06-30 | $149.96M 10-Q · filed 2024-11-05 |
| 2023-03-31 | $157.62M 10-Q · filed 2024-11-05 |
| 2022-12-31 | $60.53M 10-K · filed 2026-02-27 |
| 2022-09-30 | $62.20M 10-Q · filed 2023-11-09 |
| 2022-06-30 | $71.71M 10-Q · filed 2023-11-09 |
| 2022-03-31 | $86.82M 10-Q · filed 2023-11-09 |
| 2021-12-31 | $93.07M 10-K · filed 2025-02-27 |
| 2021-09-30 | $97.37M 10-Q · filed 2022-11-09 |
| 2021-06-30 | $102.91M 10-Q · filed 2022-11-09 |
| 2021-03-31 | -$684.00K 10-Q · filed 2022-11-09 |
| 2020-12-31 | $776.00K 10-K · filed 2024-02-27 |
| 2020-09-30 | -$2.45M 10-Q · filed 2021-11-04 |
| 2020-06-30 | $79.00K 10-Q · filed 2021-11-04 |
| 2020-03-31 | $1.80M 10-Q · filed 2021-08-05 |
| 2019-12-31 | $3.16M 10-K · filed 2023-03-08 |
| 2018-12-31 | $5.95M 10-K · filed 2022-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |